InsidersTradesSigma
艾迪药业 Stock: price and management transactions · China · SSE / SZSE (CSRC)
Follow the 艾迪药业 share price and the full management transaction log of the company, a listed issuer based in China. Shares are listed on CN CN, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 艾迪药业 has logged 12 reports. Market capitalisation: €5.3bn. The latest transaction was reported on 2 June 2026 (Purchase). Among the most active insiders: 傅和亮. The full history is openly available.
12
Insider Decl.
0
Thresholds
·
11 ops.
Buy Volume
·
1 ops.
Sell Volume
21Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 19,380 of 25,791 companies
34.6
score / 100
Value33
Quality37
FCF yld-0.5%
Earn yld-0.3%
EV/EBITDA·
ROE-0.3%
Gross mgn67%
Net mgn-2.7%
Debt/EBITDA5.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 2 June 2026
Declarations12 total
12 of 12 declarations